EE360 Health Care Resource Utilization With Asciminib and Bosutinib Among Adults With Chronic Myeloid Leukemia in Chronic Phase Previously Treated With ≥2 Tyrosine Kinase Inhibitors: Week 48 and Week 96 Results From ASCEMBL Trial

Saved in:
Bibliographic Details
Published in:Value in health 2022-12, Vol.25 (12), p.S125-S126
Main Authors: Cortes, JE, Sasaki, K, Réa, D, Mauro, MJ, Tran, D, Wang, P, Jadhav, K, Di Caprio, L, Yocolly, A
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.606